511 related articles for article (PubMed ID: 10711913)
1. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
[TBL] [Abstract][Full Text] [Related]
2. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
[TBL] [Abstract][Full Text] [Related]
3. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
4. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists.
Krupitsky EM; Burakov AM; Romanova TN; Grinenko NI; Grinenko AY; Fletcher J; Petrakis IL; Krystal JH
Neuropsychopharmacology; 2001 Dec; 25(6):936-47. PubMed ID: 11750186
[TBL] [Abstract][Full Text] [Related]
6. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study.
Rowland LM; Bustillo JR; Mullins PG; Jung RE; Lenroot R; Landgraf E; Barrow R; Yeo R; Lauriello J; Brooks WM
Am J Psychiatry; 2005 Feb; 162(2):394-6. PubMed ID: 15677610
[TBL] [Abstract][Full Text] [Related]
7. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
Parwani A; Weiler MA; Blaxton TA; Warfel D; Hardin M; Frey K; Lahti AC
Psychopharmacology (Berl); 2005 Dec; 183(3):265-74. PubMed ID: 16220331
[TBL] [Abstract][Full Text] [Related]
8. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.
Petrakis IL; Limoncelli D; Gueorguieva R; Jatlow P; Boutros NN; Trevisan L; Gelernter J; Krystal JH
Am J Psychiatry; 2004 Oct; 161(10):1776-82. PubMed ID: 15465973
[TBL] [Abstract][Full Text] [Related]
9. [Effects of a subanaesthetic dose of ketamine on emotional and behavioral state in healthy subjects].
Micallef J; Tardieu S; Gentile S; Fakra E; Jouve E; Sambuc R; Blin O
Neurophysiol Clin; 2003 Jun; 33(3):138-47. PubMed ID: 12909392
[TBL] [Abstract][Full Text] [Related]
10. Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.
Krystal JH; Anand A; Moghaddam B
Arch Gen Psychiatry; 2002 Jul; 59(7):663-4. PubMed ID: 12090822
[No Abstract] [Full Text] [Related]
11. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
Krystal JH; Abi-Saab W; Perry E; D'Souza DC; Liu N; Gueorguieva R; McDougall L; Hunsberger T; Belger A; Levine L; Breier A
Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376
[TBL] [Abstract][Full Text] [Related]
12. Is NMDA receptor hypofunction in schizophrenia associated with a primary hyperglutamatergic state?
Shim SS; Adityanjee
Arch Gen Psychiatry; 2002 May; 59(5):466-7; author reply 467-8. PubMed ID: 11982452
[No Abstract] [Full Text] [Related]
13. Subtle effects of ketamine on memory when administered following stimulus presentation.
LaPorte DJ; Blaxton TA; Michaelidis T; Robertson DU; Weiler MA; Tamminga CA; Lahti AC
Psychopharmacology (Berl); 2005 Jul; 180(3):385-90. PubMed ID: 15719220
[TBL] [Abstract][Full Text] [Related]
14. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
[TBL] [Abstract][Full Text] [Related]
15. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.
Malhotra AK; Pinals DA; Adler CM; Elman I; Clifton A; Pickar D; Breier A
Neuropsychopharmacology; 1997 Sep; 17(3):141-50. PubMed ID: 9272481
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects.
Shcherbinin S; Doyle O; Zelaya FO; de Simoni S; Mehta MA; Schwarz AJ
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4191-204. PubMed ID: 26223493
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242.
Ranganathan M; DeMartinis N; Huguenel B; Gaudreault F; Bednar MM; Shaffer CL; Gupta S; Cahill J; Sherif MA; Mancuso J; Zumpano L; D'Souza DC
Mol Psychiatry; 2017 Nov; 22(11):1633-1640. PubMed ID: 28242871
[TBL] [Abstract][Full Text] [Related]
18. Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.
Krystal JH; Petrakis IL; Limoncelli D; Webb E; Gueorgueva R; D'Souza DC; Boutros NN; Trevisan L; Charney DS
Neuropsychopharmacology; 2003 Nov; 28(11):2020-8. PubMed ID: 12888778
[TBL] [Abstract][Full Text] [Related]
19. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
[TBL] [Abstract][Full Text] [Related]
20. Selective cognitive impairments associated with NMDA receptor blockade in humans.
Rowland LM; Astur RS; Jung RE; Bustillo JR; Lauriello J; Yeo RA
Neuropsychopharmacology; 2005 Mar; 30(3):633-9. PubMed ID: 15647751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
